Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariane C Gomes

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Vaccines|February 21, 2017
Harnessing Nanoparticles for Immunomodulation and VaccinesAriane C Gomes, Mona Mohsen, Martin F Bachmann
Vaccines|July 20, 2019
The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ TransplantationAriane C Gomes, Paul D Griffiths, Matthew B Reeves
Vaccines|July 14, 2018
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune SystemMona O Mohsen, Ariane C Gomes, Monique Vogel, et al.
Vaccines|June 7, 2019
Type of RNA Packed in VLPs Impacts IgG Class Switching-Implications for an Influenza Vaccine DesignAriane C Gomes, E S Roesti, Aadil El-Turabi, et al.
Frontiers in Immunology|August 21, 2019
Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2Ariane C Gomes, Mona O Mohsen, Julius E Mueller, et al.
Frontiers in Immunology|March 22, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based VaccinesAriane C Gomes, Anna Flace, Philippe Saudan, et al.
Immunology|December 7, 2020
IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirusSaima Siddiqui, Sarah Hackl, Hamid Ghoddusi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccinationMona O Mohsen, Ariane C Gomes, Gustavo Cabral-Miranda, et al.
Ebiomedicine|November 19, 2019
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantationIlona Baraniak, Ariane C Gomes, Isabella Sodi, et al.
The Journal of General Virology|June 13, 2023
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' seraAriane C Gomes, Ilona A Baraniak, Megan R McIntosh, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Vaccines|February 21, 2017
Harnessing Nanoparticles for Immunomodulation and VaccinesAriane C Gomes, Mona Mohsen, Martin F Bachmann
Vaccines|July 20, 2019
The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ TransplantationAriane C Gomes, Paul D Griffiths, Matthew B Reeves
Vaccines|July 14, 2018
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune SystemMona O Mohsen, Ariane C Gomes, Monique Vogel, et al.
Vaccines|June 7, 2019
Type of RNA Packed in VLPs Impacts IgG Class Switching-Implications for an Influenza Vaccine DesignAriane C Gomes, E S Roesti, Aadil El-Turabi, et al.
Frontiers in Immunology|August 21, 2019
Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2Ariane C Gomes, Mona O Mohsen, Julius E Mueller, et al.
Frontiers in Immunology|March 22, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based VaccinesAriane C Gomes, Anna Flace, Philippe Saudan, et al.
Immunology|December 7, 2020
IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirusSaima Siddiqui, Sarah Hackl, Hamid Ghoddusi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2017
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccinationMona O Mohsen, Ariane C Gomes, Gustavo Cabral-Miranda, et al.
Ebiomedicine|November 19, 2019
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantationIlona Baraniak, Ariane C Gomes, Isabella Sodi, et al.
The Journal of General Virology|June 13, 2023
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' seraAriane C Gomes, Ilona A Baraniak, Megan R McIntosh, et al.
Pageof 2